InformasjonGenital herpesinfeksjon kan ha typiske symptomer som at de ytre kjønnsorganene blir røde, hovne og ømme, og det dannes smertefulle blemmer.
Genital herpesinfeksjon
Genital herpes er en infeksjon i underlivet med herpes simplex virus (HSV). Første utbrudd kommer oftest få dager til uker etter smitte, senere kan infeksjonen komme tilbake gjentatte ganger, men med langt mindre plager.
Sist oppdatert:
22. juli 2020
Vil du vite mer
Dette dokumentet er basert på det profesjonelle dokumentet Herpes genitalis hos kvinner . Referanselisten for dette dokumentet vises nedenfor
Referanser
- Folkehelseinstituttet. Herpes simplexvirus-infeksjoner - veileder for helsepersonell. Smittevernveilederen. Sist oppdatert 17.04.2019. Siden lest 01.12.2022
- Bernstein DI, Bellamy AR, Hook EW III, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis. 2013;56(3):344–351.
- Groves MJ. Genital herpes: a review. Am Fam Physician. 2016 Jun 1;93(11):928-934.
- Hartgill U, Peterson H, Rimstad L. Vulvovaginale infeksjoner. Veileder i generell gynekologi. Norsk gynekologisk forening, 2015. legeforeningen.no
- Rygh A, Kvalvik SA, Moksnes LR, Spydslaug A. Norsk gynekologisk forening. Gential herpes. Veileder i gynekologi 2021. Siden lest 12.12.2022 www.legeforeningen.no
- Tata S, Johnston C, Huang ML, et al. Overlapping reactivations of herpes simplex virus type 2 in the genital and perianal mucosa. J Infect Dis. 2010;201(4):499–504.
- Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000; 342: 844-50. DOI: 10.1056/NEJM200003233421203 DOI
- Tronstein E, Johnston C, Huang M-L, et al. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA 2011; 305: 1441-9. Journal of the American Medical Association
- Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999; 341: 1432 - 8. New England Journal of Medicine
- Johnston C, Magaret A, Son H, et al. Viral Shedding 1 Year Following First-Episode Genital HSV-1 Infection. JAMA 2022. pmid:36272098 PubMed
- Donovan B. Sexually transmissible infections other than HIV. Lancet 2004; 363: 545-56. PubMed
- Lautenschlager S, Eichmann A. The heterogeneous clinical spectrum of genital herpes. Dermatology 2001; 202: 211-9. PMID: 11385226 PubMed
- Findal G, Nodenes K, Kro GAB, Barlinn R. Genital herpes i Veileder i fødselshjelp. Norsk gynekologisk forening 2020. Siden lest 12.12.2022 www.legeforeningen.no
- Wald A, et al. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis. 2003;188(9):1345–1351.
- Nilsen A. Systemisk antiviral behandling ved herpes genitalis. Tidsskr Nor Lægeforen 2002; 122: 2805-6. PubMed
- Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, et al, for the valacyclovir HSV transmission study group. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350: 11-20. New England Journal of Medicine
- Johnston C, Saracino M, Kuntz S, et al. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials. Lancet 2012; doi:10.1016/S0140-6736(11)61750-9. DOI
- Skiveren J, Bermark S, et al.: Klinisk retningslinje for rensning af akutte og kroniske sår: Sæbe, skyllevæsker og skylletryk. Sist revidert 31.07.2017. Center for kliniske retningslinjer, Aalborg Universitet. www.cfkr.dk
- Kimberlin DW, Rouse DJ. Genital herpes. N Engl J Med 2004; 350: 1970-7. PubMed
- Le Cleach L, Trinquart L, Do G, et al. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients. Cochrane Database Syst Rev. 2014 8:CD009036. doi: 10.1002/14651858.CD009036.pub2. DOI
- Drake S, Taylor S, Brown D, Pillay D. Improving the care of patients with genital herpes. BMJ 2000; 321:619-23. British Medical Journal
- Cowan FM, Pascoe SJ, Barlow KL, et al. A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers. Sex Transm Infect 2008; 84: 548-53. PubMed
- Belshe RB, Leone PA, Bernstein DI, et al. Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med 2012; 366: 34-43. New England Journal of Medicine
- Dunphy K. Herpes genitalis and the philosopher's stance. J Med Ethics. 2014;40(12):793–797.
- Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20: 73-83. PubMed
- Corey L. Synergistic copathogens—HIV-1 and HSV-2. N Engl J Med. 2007;356(8):854–856.